Pharmacovigilance study of drug-induced eye movement disorder based on FDA adverse event reports from 2004 to 2024. [PDF]
Hong SY +5 more
europepmc +1 more source
Plasma taurine levels are not affected by vigabatrin in pediatric patients
Emily M. Spelbrink +3 more
semanticscholar +1 more source
Effects of vigabatrin on partial seizures and cognitive function. [PDF]
R A Grünewald +5 more
openalex +1 more source
Visual Function Characteristics in <i>STXBP1</i> Epileptic Encephalopathy Patients. [PDF]
Rosa A +11 more
europepmc +1 more source
Vigabatrin in Medically Resistant Epilepsies - A Preliminary Experience with Nine Saudi Children
Ahmed Al Jarallah, Generoso G. Gascon
openalex +1 more source
Mechanistic strategies for secondary prevention of developmental and epileptic encephalopathy in children with tuberous sclerosis complex. [PDF]
Specchio N +4 more
europepmc +1 more source
"Time to Feed the Baby": Should There Be a Paradigm Change in the Treatment of Infantile Epileptic Spasms Syndrome? [PDF]
Phitsanuwong C.
europepmc +1 more source
CPP‐115, a vigabatrin analogue, decreases spasms in the multiple‐hit rat model of infantile spasms
Stephen W. Briggs +3 more
semanticscholar +1 more source
Investigation into visual defects attributed to Vigabatrin
Miriam L. Conway
openalex +1 more source

